De-risking and accelerating clinical trials through more sensitive and complete data about patients’ function in real-life

Innovation in pharma is risky and slow because of the bottleneck of clinical trials, which do not produce adequate data:

  • 70-75% of all pharma R&D spend

  • Up to 1 in 3 fail to produce required data

  • Typically take 7-10 years

  • Cost >$10s of Millions

Clinical trials are risky, slow and costly because of inadequate data:

  • Slow & difficult to recruit & retain participants and ensure adherence

  • Often subjective or not quantitative

  • Not sensitive enough

  • Not complete, lack relevant context

  • Not real-world, does not represent meaningful changes in function in real-life

WKD.SMRT’s solution is a user-friendly in-home IoT+AI platform that delivers superior data for neurodegenerative and other diseases that involve motor dysfunction or changes in activity in real-life

WKD.SMRT’s platform combines multiple IoT sensor nodes with edge computing for AI processing, a tablet for patient interaction, and a hub that provides WiFi and 5G for connectivity to WKD.SMRT’s cloud, which delivers data-as-a-service via secure APIs

Insights

About Us

We are the right team, at the right time. WKD.SMRT was founded by a team of professors and CTOs from MIT and Dartmouth. We recognize the potential of smart-home technologies to accelerate clinical trials. With technology and medical expertise, and entrepreneurial experience we are in the right place to innovate. Recent enabling innovation, in particular in vision, sensing and machine learning, now makes this doable.

Let’s Talk

  • Are you responsible for implementing digital technology to clinical trials in your organization?

  • Do you have a burning passion to transform how clinical trials are run?

  • Or just wicked smart and curious about what we are making?

Newsletter Sign Up

Stay involved with our latest developments.

Join Our Team

Interested in joining our team of skilled innovative individuals?